ICER’s Dr. Steve Pearson and the COVID drug pricing model

HealthBiz with David E. Williams

English - November 12, 2020 05:00 - 33 minutes - 22.7 MB - ★★★★★ - 42 ratings
Management Business healthcare business health care healthcare policy entrepreneurship ceo interview Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Jean Mixer: Boston Children’s digital health maven

Next Episode: Niall Brennan brings data to the healthcare party

Drug pricing is the hottest topic in healthcare, and ICER founder Dr. Steve Pearson is the coolest person to discuss it with. In this episode of the HealthBiz podcast, Steve describes how ICER compiles and analyzes clinical evidence to estimate the fair value of treatments for COVID-19 and other serious illnesses.

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.